[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-464428-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-464428-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","trends-in-survival-and-mortality-of-early-metastatic-breast-cancer-in-northern-italy-following-the-introduction-of-targeted-therapies","Trends in Survival and Mortality of “Early” Metastatic Breast Cancer in Northern Italy Following the Introduction of Targeted Therapies","","Long-term population-based analysis evaluates how “early” metastatic breast cancer burden and outcomes evolved in Reggio Emilia, Northern Italy, across two decades of screening and systemic therapy changes. Incidence, mortality, and survival were assessed for 10,966 invasive breast cancer cases diagnosed 2000–2022, with “early” metastases defined as distant spread within six months of diagnosis. Joinpoint regression quantified mortality trends, and 1-, 3-, and 5-year survival probabilities were calculated through December 2024. Results show fewer early metastatic diagnoses, reduced early mortality, and improved survival temporally consistent with targeted therapy adoption and high screening coverage.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/trends-in-survival-and-mortality-of-early-metastatic-breast-cancer-in-northern-italy-following-the-introduction-of-targeted-therapies/464428/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/trends-in-survival-and-mortality-of-early-metastatic-breast-cancer-in-northern-italy-following-the-introduction-of-targeted-therapies/464428.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-30",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How did the study define “early” metastatic breast cancer?","Question",{"text":63,"@type":64},"“Early” metastatic cases were defined as those in which distant metastases occurred within six months of diagnosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What data and time period were used to assess incidence and outcomes?",{"text":68,"@type":64},"The study retrieved all invasive breast cancer cases diagnosed between 2000 and 2022 from the Reggio Emilia Cancer Registry.",{"name":70,"@type":61,"acceptedAnswer":71},"What overall trends were observed in incidence, mortality, and survival?",{"text":72,"@type":64},"Across more than two decades, the incidence of MBC at diagnosis and early mortality declined, while survival probabilities improved after diagnosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},464428,1791230211,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Article  \nTrends in Survival and Mortality of “Early” Metastatic Breast Cancer in Northern Italy Following the Introduction of Targeted Therapies  \nFrancesco Marinelli 1, Maria Barbara Braghiroli 1, Isabella Bisceglia 1, Guglielmo Ferrari 2, Fortunato Morabito 3, Filippo Giovanardi 4, Carmine Pinto 4 and Lucia Mangone 1, *  \nReceived: 18 November 2025  \nRevised: 12 December 2025  \nAccepted: 23 December 2025  \nPublished: 29 December 2025  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Epidemiology Unit, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy; [francesco.marinelli@ausl.re.it](francesco.marinelli@ausl.re.it) (F.M.); [mariabarbara.braghiroli@ausl.re.it](mariabarbara.braghiroli@ausl.re.it) (M.B.B.); [isabella.bisceglia@ausl.re.it](isabella.bisceglia@ausl.re.it) (I.B.)  \n2 Associazione “Vittorio Lodini per la Ricerca in Chirurgia” di Reggio Emilia, 42122 Reggio Emilia, Italy; [ferrariguglielmo3@gmail.com](ferrariguglielmo3@gmail.com)  \n3 AIL Sezione di Cosenza, 87100 Cosenza, Italy; fortunato.morabito@grade.it  \n4 Medical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy;  \nfilippo.giovanardi@ausl.re.it (F.G.); carmine.pinto@ausl.re.it (C.P.)  \n* Correspondence: [lucia.mangone@ausl.re.it](lucia.mangone@ausl.re.it)  \nSimple Summary  \nBreast cancer is the most common cancer among women, and its outcome largely depends on how early it is detected and how effectively it is treated. This study examined how the number of women diagnosed with metastatic breast cancer, and their chances of survival, have changed over the past two decades in the province of Reggio Emilia, Northern Italy. The region benefits from organized mammography screening and widespread access to modern, targeted treatments. The results show that fewer women are now diagnosed with“early” metastatic disease and that survival after diagnosis has improved. These findings demonstrate how the combination of early detection and advances in precision medicine can significantly improve outcomes for women with breast cancer, providing real-world evidence that progress in both screening and therapy is saving lives in the community.  \nAbstract  \nBackground/Objectives: In high-income settings, the incidence of metastatic breast cancer (MBC) at diagnosis has declined, reflecting the impact of effective screening and therapeutic advances. This study examined long-term trends in MBC incidence, mortality, and survival in a province of North Italy, an area characterized by high screening participation and broad access to modern systemic treatments. Methods: All invasive breast cancer cases (n = 10,966) diagnosed between 2000 and 2022 were retrieved from the Reggio Emilia Cancer Registry (population: 532,000) . Metastatic cases were defined “early” if distant metastases occurred within six months of diagnosis. Mortality trends were assessed using joinpoint regression to estimate annual percentage changes (APCs) . One-, three-, and five-year survival probabilities were calculated, with follow-up through December 2024 . Results: Overall, 511 cases (4.7%) were “early” metastatic breast cancers at diagnosis. This proportion declined from 6.4% in 2000–2003 to 3.8% in 2019–2022 . One-year mortality decreased from 38.4% to 26.7%(APC = −6.6; 95% CI −13.1 to −0.5), and two-year mortality from 54.5% to 34.9%(APC = −7.3; 95% CI −12.3 to −1.4) after 2017 . One-and three-year survival increased from 63% to 66% and from 39% to 42%, respectively, while five-year survival improved from 21% to 30% . Conclusions: Over more than two decades, the incidence of MBC at diagnosis and early mortality both declined, accompanied by improved survival.  \nThese trends temporally coincide with the widespread adoption of targeted therapies and sustained high screening coverage, suggesting a possible combined ","cbCait57GcUDaDd6","https://ap.wps.com/l/cbCait57GcUDaDd6","pdf",449535,12,"English","# Abstract\n## Background/Objectives\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"How did the study define “early” metastatic breast cancer?\",\"answer\":\"“Early” metastatic cases were defined as those in which distant metastases occurred within six months of diagnosis.\"},{\"question\":\"What data and time period were used to assess incidence and outcomes?\",\"answer\":\"The study retrieved all invasive breast cancer cases diagnosed between 2000 and 2022 from the Reggio Emilia Cancer Registry.\"},{\"question\":\"What overall trends were observed in incidence, mortality, and survival?\",\"answer\":\"Across more than two decades, the incidence of MBC at diagnosis and early mortality declined, while survival probabilities improved after diagnosis.\"}]","Trends in Survival and Mortality of “Early” Metastatic Breast Cancer in Northern Italy Following the Introduction of Targeted Therapies | PDF",1790768187,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/13cca4e27a0eb5232ad6a554150b7333.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/4c87752878650c684e8198ca51b528d9.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/ba0a0e6159cf3421e3bc8a607dbeb082.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/c18b404edad3663f797744337fc038ca.webp",980,1385]